Extract

The aim of this study is to evaluate the efficacy of TevaGastrim which is a biosimilar version of Filgrastim recombinant human G-CSF (G-CSF) in mobilizing sufficient number of stem cells from normal sibling donors for allogeneic stem cell transplantation.

Inclusion criteria

• Acute Myeloid Leukemia,myelodysplastic syndrome

Links

• nct
• ictrp